Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters.

[1]  G. Fields,et al.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.

[2]  P. Metharom,et al.  Breaking Immune Tolerance to the Prion Protein Using Prion Protein Peptides Plus Oligodeoxynucleotide-CpG in Mice1 , 2004, The Journal of Immunology.

[3]  M. Arbel,et al.  Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunization , 2003, Journal of Neuroimmunology.

[4]  P. Henklein,et al.  Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent , 2003, Neuroscience Letters.

[5]  K. Asadullah,et al.  Interleukin-10 Therapy—Review of a New Approach , 2003, Pharmacological Reviews.

[6]  R. Maserati,et al.  B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. , 2003, Blood.

[7]  I. Cohen,et al.  Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice , 2003, Journal of neuroscience research.

[8]  F. Checler,et al.  Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators , 2002, Trends in Neurosciences.

[9]  D. Holtzman.  Aβ conformational change is central to Alzheimer’s disease , 2002, Neurobiology of Aging.

[10]  R. Veerhuis,et al.  Neuroinflammation in Alzheimer's disease and prion disease , 2002, Glia.

[11]  C. Cunningham,et al.  Atypical inflammation in the central nervous system in prion disease , 2002, Current opinion in neurology.

[12]  V. Perry,et al.  Transforming growth factor β1, the dominant cytokine in murine prion disease: influence on inflammatory cytokine synthesis and alteration of vascular extracellular matrix , 2002, Neuropathology and applied neurobiology.

[13]  R. Dantzer,et al.  Interleukin-10 in the brain. , 2001, Critical reviews in immunology.

[14]  F. Heppner,et al.  Immunity against prions? , 2001, Trends in molecular medicine.

[15]  N. Rothwell,et al.  Cytokines and acute neurodegeneration , 2001, Nature Reviews Neuroscience.

[16]  F. Heppner,et al.  Interventional strategies against prion diseases , 2001, Nature Reviews Neuroscience.

[17]  F. Heppner,et al.  Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies , 2001, Science.

[18]  Pauline M. Rudd,et al.  Antibodies inhibit prion propagation and clear cell cultures of prion infectivity , 2001, Nature.

[19]  E. Sigurdsson,et al.  Therapeutics in Alzheimer's and prion diseases. , 2001, Biochemical Society transactions.

[20]  I. Cohen,et al.  Modulation of proteinase‐K resistant prion protein by prion peptide immunization , 2001, European journal of immunology.

[21]  M. Enari,et al.  Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  David R. Brown,et al.  Microglia and prion disease , 2001, Microscopy research and technique.

[23]  Ralph A. Nixon,et al.  Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.

[24]  David R. Brown,et al.  A Model for the Mechanism of Astrogliosis in Prion Disease , 2000, Molecular and Cellular Neuroscience.

[25]  R. Motter,et al.  Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.

[26]  H. Wiśniewski,et al.  Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. , 1999, Brain research. Molecular brain research.

[27]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[28]  F. Tagliavini,et al.  Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. , 1999, Neuroreport.

[29]  T. Wisniewski,et al.  Prion diseases and the immune system. , 1999, Annales de medecine interne.

[30]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[31]  S. Prusiner,et al.  Molecular biology and pathogenesis of prion diseases. , 1996, Trends in biochemical sciences.

[32]  P. Liberski,et al.  Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Forloni,et al.  Amyloid in alzheimer's disease and prion-related encephalopathies: Studies with synthetic peptides , 1996, Progress in Neurobiology.

[34]  H. Fraser,et al.  Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice , 1994, Brain Research.

[35]  M. Pocchiari,et al.  Detection of proteinase-resistant protein (PrP) in small brain tissue samples from Creutzfeldt-Jakob disease patients , 1994, Journal of the Neurological Sciences.

[36]  I. Campbell,et al.  Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie , 1994, Journal of virology.

[37]  D. King,et al.  A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. , 1990, International journal of peptide and protein research.

[38]  D. Katz,et al.  New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. , 1979, Biochemistry.

[39]  H. Fraser,et al.  The sequential development of the brain lesion of scrapie in three strains of mice. , 1968, Journal of comparative pathology.

[40]  C. Hetz,et al.  Protein misfolding and disease: the case of prion disorders , 2003, Cellular and Molecular Life Sciences CMLS.

[41]  J. Collinge.  Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[42]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[43]  P. Liberski,et al.  Molecular analysis of prion protein (PrP) and glial fibrillary acidic protein (GFAP) transcripts in experimental Creutzfeldt-Jakob disease in mice. , 1997, Acta neurobiologiae experimentalis.